251 related articles for article (PubMed ID: 11466682)
1. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
[TBL] [Abstract][Full Text] [Related]
5. TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome.
Migliavacca M; Ottini L; Bazan V; Agnese V; Corsale S; Macaluso M; Lupi R; Dardanoni G; Valerio MR; Pantuso G; Di Fede G; Tomasino RM; Gebbia N; Mariani-Costantini R; Russo A
J Cell Physiol; 2004 Sep; 200(3):476-85. PubMed ID: 15254976
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA analysis and lysosomal cathepsins B and L in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance.
Russo A; Bazan V; Gebbia N; Pizzolanti G; Tumminello FM; Dardanoni G; Ingria F; Restivo S; Tomasino RM; Leto G
Cancer; 1995 Nov; 76(10):1757-64. PubMed ID: 8625044
[TBL] [Abstract][Full Text] [Related]
7. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
Setälä LP; Nordling S; Kosma VM; Lipponen PK; Eskelinen MJ; Hollmén SM; Syrjänen KJ; Alhava EM
Anal Quant Cytol Histol; 1997 Dec; 19(6):524-32. PubMed ID: 9893908
[TBL] [Abstract][Full Text] [Related]
8. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study.
Nesi G; Bruno L; Saieva C; Caldini A; Girardi LR; Zanna I; Rapi S; Bechi P; Cortesini C; Palli D
Anticancer Res; 2007; 27(6C):4435-41. PubMed ID: 18214057
[TBL] [Abstract][Full Text] [Related]
10. Is DNA aneuploidy a prognostic factor in gastric cancer?
Omejc M; Repse S; Bracko M
Acta Chir Hung; 1997; 36(1-4):266-9. PubMed ID: 9408370
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.
Russo A; Migliavacca M; Bazan V; Maturi N; Morello V; Dardanoni G; Modica G; Bazan P; Albanese I; La Farina M; Tomasino RM
Cell Prolif; 1998; 31(3-4):139-53. PubMed ID: 9853427
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
15. Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer.
Geido E; Sciutto A; Rubagotti A; Oliani C; Monaco R; Risio M; Giaretti W
Cytometry; 2002 Aug; 50(4):216-24. PubMed ID: 12210601
[TBL] [Abstract][Full Text] [Related]
16. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
[TBL] [Abstract][Full Text] [Related]
18. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
19. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
Bazan V; Bruno L; Augello C; Agnese V; Calò V; Corsale S; Gargano G; Terrasi M; Schirò V; Di Fede G; Adamo V; Intrivici C; Crosta A; Rinaldi G; Latteri F; Dardanoni G; Grassi N; Valerio MR; Colucci G; Macaluso M; Russo A;
Ann Oncol; 2006 Jun; 17 Suppl 7():vii84-90. PubMed ID: 16760301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
